EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 2 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,193 | +78.4% | 75,133 | +295.4% | 0.00% | – |
| Q2 2023 | $140,250 | -36.3% | 19,004 | -10.1% | 0.00% | – |
| Q1 2023 | $220,185 | -31.5% | 21,131 | -24.1% | 0.00% | – |
| Q4 2022 | $321,480 | -36.7% | 27,846 | +73.5% | 0.00% | -100.0% |
| Q2 2022 | $508,000 | -39.6% | 16,053 | -20.4% | 0.00% | 0.0% |
| Q1 2022 | $841,000 | +120.2% | 20,169 | +134.5% | 0.00% | – |
| Q4 2021 | $382,000 | -90.1% | 8,600 | -80.1% | 0.00% | -100.0% |
| Q4 2020 | $3,876,000 | -36.0% | 43,277 | -26.1% | 0.01% | -50.0% |
| Q3 2020 | $6,057,000 | +815.0% | 58,585 | +599.5% | 0.01% | +900.0% |
| Q2 2020 | $662,000 | +48.8% | 8,375 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $445,000 | +99.6% | 7,692 | +73.4% | 0.00% | – |
| Q1 2019 | $223,000 | – | 4,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
| Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
| SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
| CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
| Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
| DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |